Explore
New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges
Ahmed Bakillah
2019
0 Ungluers have
Faved this Work
Login to Fave
This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 177 times via unglue.it ebook links.
- 146 - pdf (CC BY-NC-ND) at Unglue.it.
Keywords
- ABCA1
- acute coronary syndrome
- acute kidney injury
- anacetrapib
- apolipoprotein
- Atherosclerosis
- Atrial Fibrillation
- Cardiovascular Disease
- cardiovascular disease (CVD)
- Cardiovascular Diseases
- cardiovascular risk
- ceramides
- cholesterol
- cholesteryl ester transfer protein
- circular RNA
- coronary artery bypass grafting
- diabetes
- dyslipidemia
- Gene expression
- Genetic
- HDL
- hepatic fibrosis
- hyperlipidemia
- inclisiran
- LDL subfractions
- Lipids
- lipoproteins
- low-density lipoprotein cholesterol
- low-density lipoprotein-cholesterol (LDL-C)
- miRNA
- NAFLD
- NASH
- nonstatin
- NSTEMI
- Nutrigenetics
- PCSK9
- pleiotropic actions
- proprotein convertase subtilisin-kexin type 9 (PCSK9)
- proprotein convertase subtilisin/kexin type 9
- reverse cholesterol transport
- risk stratification
- RNA-binding proteins
- sdLDL
- small interfering RNA (siRNA)
- sphingolipids
- sphingomyelin
- statin
- statins
- STEMI
- sterol
- Stroke
- type 2 diabetes
- vaspin
Links
DOI: 10.3390/books978-3-03921-677-2Editions
